射频消融治疗甲状腺乳头状癌的研究进展

doi:10.13481/j.1671-587x.20190346

摘要/Abstract

摘要： 射频消融（RFA）是在超声引导下利用高频交变电流所释放出的能量使局部组织产生高温，使病灶凝固坏死，进而消除病灶的一种热消融方法。RFA技术现已广泛应用于肝癌、肾癌、肺癌和甲状腺良性结节等疾病的治疗中。对于甲状腺乳头状癌（PTC）最主要的治疗方式仍是手术治疗，然而手术治疗可能会带来各种并发症，增加患者的心理负担。目前RFA已经应用于PTC原发灶、PTC局部复发灶、PTC转移淋巴结及PTC远处转移的治疗当中。另外，在RFA治疗甲状腺疾病过程中，必须严格把握其适应证。本文通过阐述RFA、RFA在PTC中的应用及RFA的并发症，对RFA技术应用于PTC的研究进展作一综述。

关键词: 甲状腺乳头状癌, 射频消融, 肿瘤转移, 并发症

中图分类号:

R736.1

石亮, 逄仁柱, 李锐, 孟庆哲, 王政民, 杨帅, 孟倩怡, 颜炜, 孟宪瑛. 射频消融治疗甲状腺乳头状癌的研究进展[J]. 吉林大学学报(医学版), 2019, 45(03): 731-735.

参考文献

[1] 潘明, 陈闯, 牛志昊,等. 射频消融治疗甲状腺乳头状癌的临床进展[J]. 中国地方病防治杂志, 2015(3):182-183.
[2] HAUGEN B R. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:What is new and what has changed?[J].Cancer,2017,123(3):372-381.
[3] CHANG H, KIM SM, CHUN KW, et al.Clinicopathologic features of solid variant papillary thyroid cancer[J]. ANZ J Surg,2014,84(5):380-382.
[4] KIM J H, YOO W S, PARK Y J, et al. Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm[J]. Radiology, 2015,276(3):909-918.
[5] GARBEROGLIO R, ALIBERTI C, APPETECCHIA M, et al. Radiofrequency ablation for thyroid nodules:which indications? The first Italian opinion statement[J]. J Ultrasound, 2015, 18(4):423-430.
[6] 周茂胜, 常欣. 射频消融原理及应用[J]. 当代医学, 2009, 15(21):18-19.
[7] SHIN J E, BAEK J H, LEE J H. Radiofrequency and ethanol ablation for the treatment of recurrent thyroid cancers:Current status and challenges[J]. Current Opinion Oncol, 2012, 25(1):14-19.
[8] FRANZ A M, SEITEL A, BOPP N, et al. First clinical use of the EchoTrack guidance approach for radiofrequency ablation of thyroid gland nodules[J]. Int J Computer Assisted Radiol Surg, 2017, 12(6):931-940.
[9] 刘池拽, 邓建伟, 师天雄. RFA技术在甲状腺疾病中的临床进展[J]. 中华普通外科学文献:电子版, 2015(3):54-57.
[10] XIAOYIN T, DAN C, JIACHANG C, et al. Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules[J]. J Cancer, 2017, 8(5):754-760.
[11] KIM J H, BAEK J H, SUNG J Y, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma:preliminary results for patients ineligible for surgery[J]. Int Hyperthermia, 2017, 33(2):8.
[12] GUAN Y, LUO Y, ZHANG Y, et al. Efficacy and safety of percutaneous ultrasound guided radiofrequency ablation for treating cervical metastatic lymph nodes from papillary thyroid carcinoma[J]. J Cancer Res Clin Oncol, 2017,143(8):1555-1562.
[13] KIM C, LEE J H, CHOI Y J, et al. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers[J]. Eur Radiol, 2017, 27(8):3128-3137.
[14] 李建如, 罗渝昆, 李岩密,等. 超声引导下RFA治疗甲状腺微小乳头状癌的疗效分析[J]. 解放军医学院学报, 2016, 37(8):823-826.
[15] 刘晓岭, 黄靖, 孙德胜,等. 超声引导下RFA治疗甲状腺微小乳头状癌的临床体会[J]. 黑龙江医学, 2015(1):69-70.
[16] LONG B, LI L, YAO L, et al. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma[J]. J Cancer Res Therap, 2015, 11(Suppl 8):C244.
[17] MONCHIK J M, DONATINI G, IANNUCCILLI J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma[J]. Ann Surg, 2006, 244(2):296-304.
[18] XU D, CHEN L, QIAN C, et al. Ultrasonography-guided percutaneous radiofrequency ablation for cervical lymph node metastasis from thyroid carcinoma[J]. J Cancer Res Therapeut, 2014, 10(7):144.
[19] 张丹琦,赵滨滨,张素冰. 针刺复合舒芬太尼麻醉在微创甲状腺RFA术中的应用[A]. 中国中西医结合麻醉学会[CSIA]年会暨第二届全国中西医结合麻醉学术研讨会、江苏省中西医结合学会麻醉专业委员会成立大会论文汇编[C]. 扬州:2015.
[20] ITO Y, MIYAUCHI A, KIHARA M, et al. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation[J]. Thyroid, 24(1):27-34.
[21] JEONG S Y, BAEK J H, CHOI Y J, et al.Radiofrequency ablation of primary thyroid carcinoma:efficacy according to the types of thyroid carcinoma[J]. Int J Hyperthermia, 2018,34(5):611-616.
[22] 董文武, 张浩, 张平,等. 甲状腺乳头状癌射频消融治疗后再手术5例临床分析[J]. 中国实用外科杂志, 2015, 35(6):653-655.
[23] YANG L, TANG H, LEE A M, et al. Risk of malignancy in symptomatic nodular goiter treated with radiofrequency ablation[J]. AJNR Am Neuroradiol, 2015, 37(1):E7.
[24] 田文, 王宇, 郗洪庆,等. 甲状腺疾病RFA治疗现状与争议[J]. 中国实用外科杂志, 2018,38(1):75-78.
[25] LIM H K, BAEK J H, LEE J H, et al. Efficacy and safety of radiofrequency ablation for treating locoregional recurrence from papillary thyroid cancer[J]. Eur Radiol, 2015, 25(1):163-170.
[26] ZHAO Q, TIAN G, KONG D. Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers[J]. J Endocrinol Invest, 2016, 39(8):909-916.
[27] MAZZEO S, CERVELLI R, ELISEI R, et al. mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation:a prospective study[J]. J Endocrinol Invest,2018,41(12):1389-1399.
[28] 广旸, 罗渝昆, 张艳,等. 超声引导下RFA治疗PTC颈部转移淋巴结的疗效评价[J]. 中国医学科学院学报, 2018(1),40(1):67-71.
[29] BAEK J H, NA D G, PARK H S. RE:Management of low-risk papillary thyroid microcarcinoma[J]. Korean J Radiol, 2017, 18(2):408-409.
[30] CAZZATO R L, BONICHON F, BUY X, et al. Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer[J]. Eur J Surg Oncol,2015,41(9):1247-1255.
[31] KIM M, KIM W G, PARK S, et al. Growth kinetics of macronodular lung metastases and survival in differentiated thyroid carcinoma[J]. Thyroid, 2017,27(7):915-922.
[32] MASSICOTTE M H, BRASSARD M, CLAUDE-DESROCHES M, et al. Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas:a retrospective study of the TUTHYREF network[J]. Eur J Endocrinol, 2014, 170(4):575-582.
[33] 隋洋, 吴凤林, 孙医学. 超声引导下RFA甲状腺结节的并发症与预防方法探讨[J]. 医学影像学杂志, 2014, 24(1):32-35.
[34] KIM J H, BAEK J H, SUNG J Y, et al. Radiofrequency ablation of low-risk small papillary thyroidcarcinoma:preliminary results for patients ineligible for surgery[J]. Int J Hyperthermia, 2017,33(2):212-219.
[35] 娄雪峰, 吴凤林, 纪莉,等. RFA高风险甲状腺结节避免喉返神经损伤的方法探讨[J]. 中国超声医学杂志, 2014, 30(7):577-580.
[36] BERNARDI S, LANZILOTTI V, PAPA G, et al.Full-thickness skin burn caused by radiofrequency ablation of a benign thyroid nodule[J]. Thyroid, 2016,26(1):183-184.
[37] 马建新, 杜大勇, 李运田. 甲状腺功能减退患者RFA术后出现意识模糊一例[J]. 中国心脏起搏与心电生理杂志, 2009, 23(3):268-268.
[38] ODDO S, SPINA B, VELLONE V G, et al. A case of thyroid cancer on the track of the radiofrequency electrode 30 months after percutaneous ablation[J]. J Endocrinol Invest, 2017,40(1):101-102.
[39] LEE C U, KIM S J, SUNG J Y, et al. Needle track tumor seeding after radiofrequency ablation of a thyroid tumor[J]. Japan J Radiol, 2014, 32(11):661-663.